Amarin Corp Plc (AMRN)

[sts66]

Are you sure that plan went into effect? Appears the bill is still being negotiated:

https://www.globalcompliancenews.com/2022/07/19/germany-german-government-announces-bill-to-drastically-slash-drug-reimbursement-08072022/

On 8 July 2022, the German Health Ministry has officially shared the second edition of a new bill referred to as the Act for Financial Stability of the Public Health Insurance (GKV-Finanzstabilisierungsgesetz, “GKV-FinStG“). The bill is still subject to discussions with stakeholders and several rounds of congress hearings. If ultimately implemented, which is a likely scenario, pharma companies will face several painful cutbacks on the statutory reimbursement of prescription-only (“Rx“) medicinal products. The dawning global economic crises, foreshadowing diminished funding available to the German statutory health insurance (SHI) funds, may accelerate the momentum for signing the bill into law.

Pharmaceutical companies should brace themselves for yet more pressure on revenues, and wherever possible take proactive actions to get adequately prepared.